tiprankstipranks
Shinpoong Pharmaceutical Co., Ltd. (KR:019170)
:019170
South Korea Market
019170
Shinpoong Pharmaceutical Co., Ltd.
RESEARCH TOOLSreports

Shinpoong Pharmaceutical Co., Ltd. (019170) Financial Statements

― Followers

Shinpoong Pharmaceutical Co., Ltd. Financial Overview

Shinpoong Pharmaceutical Co., Ltd.'s market cap is currently ₩514.61B. The company's EPS TTM is ₩-9.55; its P/E ratio is -1,048.17; and it has a dividend yield of 0.08%. Shinpoong Pharmaceutical Co., Ltd. is scheduled to report earnings on August 14, 2026, and the estimated EPS forecast is ₩―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue₩ 234.68B₩ 221.09B₩ 200.23B₩ 209.29B₩ 189.24B
Gross Profit₩ 102.37B₩ 81.80B₩ 80.28B₩ 77.97B₩ 77.39B
Operating Income₩ 14.26B₩ -20.46B₩ -47.39B₩ -34.02B₩ -9.04B
EBITDA₩ 25.65B₩ -27.14M₩ -39.81B₩ -21.92B₩ 1.27B
Net Income₩ 8.83B₩ -15.39B₩ -57.33B₩ -35.31B₩ -11.53B
Balance Sheet
Cash & Short-Term Investments₩ 71.50B₩ 56.46B₩ 60.46B₩ 55.92B₩ 92.70B
Total Assets₩ 352.47B₩ 342.09B₩ 350.08B₩ 361.54B₩ 392.58B
Total Debt₩ 55.86B₩ 54.60B₩ 46.15B₩ 1.93B₩ 1.18B
Net Debt₩ 8.42B₩ 12.61B₩ 2.35B₩ -39.76B₩ -26.46B
Total Liabilities₩ 81.74B₩ 84.00B₩ 79.30B₩ 30.78B₩ 38.03B
Stockholders' Equity₩ 269.98B₩ 256.82B₩ 269.59B₩ 329.61B₩ 353.49B
Cash Flow
Free Cash Flow₩ 13.78B₩ -21.24B₩ -39.88B₩ -32.67B₩ -76.64B
Operating Cash Flow₩ 17.25B₩ -15.15B₩ -24.85B₩ -26.44B₩ -71.03B
Investing Cash Flow₩ -14.71B₩ 5.58B₩ -16.31B₩ 43.20B₩ 49.03B
Financing Cash Flow₩ 3.70B₩ 6.20B₩ 43.24B₩ -1.87B₩ -6.42B
Currency in KRW

Shinpoong Pharmaceutical Co., Ltd. Earnings and Revenue History

Income Statement >

Shinpoong Pharmaceutical Co., Ltd. Debt to Assets

Balance Sheet >

Shinpoong Pharmaceutical Co., Ltd. Cash Flow

Cash Flow >

Shinpoong Pharmaceutical Co., Ltd. Forecast EPS vs Actual EPS

Earnings >